Kazuya Monden

Shinko, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Response to Third-Line Erlotinib in Peritoneal Carcinomatosis from Initially EGFR Mutation-Negative Lung Adenocarcinoma, Followed by the Retrospective Confirmation of EGFR Mutation-Positivity by Immunohistochemistry.

Response to Third-Line Erlotinib in Peritoneal Carcinomatosis from Initially EGFR Mutation-Negative Lung Adenocarcinoma, Followed by the Retrospective Confirmation of EGFR Mutation-Positivity by Immunohistochemistry.

Journal: Internal medicine (Tokyo, Japan)

Published: May 24, 2026

Association between fentanyl dose and willingness to undergo repeat bronchoscopy in a standardized EBUS-GS-TBB setting.

Association between fentanyl dose and willingness to undergo repeat bronchoscopy in a standardized EBUS-GS-TBB setting.

Journal: Respiratory investigation

Published: April 15, 2026

Liver Paradoxical Reaction Presenting as a Solitary Hepatic Mass During Antituberculosis Therapy: A Case Report.

Liver Paradoxical Reaction Presenting as a Solitary Hepatic Mass During Antituberculosis Therapy: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: March 26, 2026

A CASE OF SUSPECTED ALLERGIC BRONCHOPULMONARY MYCOSIS CAUSED BY SCEDOSPORIUM APIOSPERMUM THAT SHOWED CLINICAL IMPROVEMENT AFTER BRONCHOSCOPIC REMOVAL OF A MUCUS PLUG

A CASE OF SUSPECTED ALLERGIC BRONCHOPULMONARY MYCOSIS CAUSED BY SCEDOSPORIUM APIOSPERMUM THAT SHOWED CLINICAL IMPROVEMENT AFTER BRONCHOSCOPIC REMOVAL OF A MUCUS PLUG

Journal: Arerugi = [Allergy]

Published: September 20, 2023

Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment.

Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment.

Journal: Internal medicine (Tokyo, Japan)

Published: November 26, 2019

Basaloid Squamous Cell Carcinoma;Report of a Case

Basaloid Squamous Cell Carcinoma;Report of a Case

Journal: Kyobu geka. The Japanese journal of thoracic surgery

Published: July 30, 2019

Fetal Adenocarcinoma of the Lung

Fetal Adenocarcinoma of the Lung

Journal: Kyobu geka. The Japanese journal of thoracic surgery

Published: July 26, 2018

Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).

Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).

Journal: Cancer chemotherapy and pharmacology

Published: December 05, 2016

Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.

Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.

Journal: Anticancer research

Published: February 11, 2015

Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia.

Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia.

Journal: Internal medicine (Tokyo, Japan)

Published: June 03, 2014

Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancer.

Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancer.

Journal: Anticancer research

Published: January 10, 2014

Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutation.

Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutation.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 18, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026